Skip to main content
. 2022 May 2;88(10):e00371-22. doi: 10.1128/aem.00371-22

TABLE 3.

MICs of antibiotics with or without PlnA1 analogs against E. colia

Antibiotics MIC (μg/mL) MIC (μg/mL) (in combination) of:
FICIb MIC (μg/mL) (in combination) of:
FICIb
Antibiotic OP4 Antibiotic PlnA1
Ampicillin 4 4 3.13 2.0 4 25 2.0
Amoxicillin 2 2 3.13 2.0 2 25 2.0
Erythromycin 500 8 0.78 0.266 32 6.25 0.314
Streptomycin 8 8 1.56 1.5 8 25 2.0
Gentamycin 2 2 1.56 1.5 2 25 2.0
Kanamycin 4 4 1.56 1.5 4 12.5 1.5
Tetracycline 2 0.25 0.78 0.375 0.5 12.5 0.75
Oxytetracycline 2 0.25 0.78 0.375 0.5 6.25 0.5
Lincomycin 500 500 3.13 2.0 250 25 1.5
Chloramphenicol 4 4 1.56 1.5 4 25 2.0
Polymyxin B 8 4 1.56 1.0 4 12.5 1.5
Vancomycin 125 125 3.13 2.0 125 12.5 1.5
Ciprofloxacin 0.06 0.008 0.78 0.38 0.016 6.25 0.5
Norfloxacin 0.04 0.008 0.78 0.445 0.01 6.25 0.5
Trimethoprim 8 0.5 0.78 0.3125 1 6.25 0.375
Triclosan 2 1 0.78 0.75 1 12.5 1.0
Novobiocin 62.5 7.81 0.78 0.375 7.81 6.25 0.375
Fusidic acid 125 15.625 0.39 0.25 15.625 3.125 0.25
Clindamycin 250 1.95 0.78 0.2578 1.95 12.5 0.5078
Rifampicin 3.125 0.195 0.39 0.1874 0.195 6.25 0.3124
a

The indicator strain used was E. coli ATCC 35218. The MIC of PlnA1 was 25 μg/mL, and the MIC of OP4 was 3.125 μg/mL.

b

FICI values of <0.5, >0.5 to 1, >1 to <2, and ≥2 indicate synergism, additive effects, indifference, and antagonism, respectively.